Skip to Main Navigation. Each navigation link will open a list of sub navigation links.

Skip to Main Content

Apply to the University of Wyoming apply now

Global Resource Navigation

Visit Campus
Download UW Viewbook
Give to UW

School of Pharmacy

College of Health Sciences

Mary Onysko, Pharm.D., BCPS

Clinical Associate Professor of Pharmacy Practice • (303) 788-3172

Swedish Family Medicine Residency Program

Littleton, Colorado

Best Mode of Communication: E-mail

Office Hours: By appointment

Mary Onysko is a Clinical Associate Professor of Pharmacy Practice at the University of Wyoming School of Pharmacy and an Assistant Clinical Professor with the Swedish Family Medicine Residency affiliated with the University of Colorado School of Medicine in Denver. She received her doctor of pharmacy degree from Oregon State University in 2006 and completed a primary care specialty residency with Providence Physician Division in Portland, Oregon.

Dr. Onysko provides ambulatory pharmaceutical care that focuses on patients with diabetes or multiple pharmacotherapy-related problems. She is part of an integrated care team that brings the patient, patient’s family or caregiver, physician, psychologist, social worker, and pharmacist together to manage complicated health and social problems. Her primary research interests are improving teaching efficacy and optimizing team-based patient care. Personal goals include playing volleyball often, golfing regularly and getting to the mountains to ski as much as possible.


Pharm.D. 2006, Oregon State University, Corvallis, Oregon

ASHP Accredited Pharmacy Specialty Residency in Primary Care, 2007, Providence Physician Division, Providence Health and Services, Portland, Oregon

Awards and Honors:

2012 Pharmacy Practice Faculty of the Year

Professional Affiliations:

American College of Clinical Pharmacy (ACCP)

American Association of Colleges of Pharmacy (AACP)

American Society of Health Systems Pharmacy (ASHP)


Experiential Rotations

PHCY 6473 Ambulatory Pharmaceutical Care

PHCY 6465 Pre-Residency Elective

PHCY 6465 Advanced Ambulatory Pharmaceutical Care


PHCY 6152 Therapeutics I (analgesics/headache; alternative medicine)

PHCY 6251 Therapeutics II (primary and secondary prevention; migraine)

PHCY 6350 Therapeutics III (pain management)

PHCY 6351 Therapeutics IV (cardiology)

National Presentations:

Onysko M. “The tortoise and the hare of chronic kidney disease: Slowing progression of diabetic nephropathy” – Podium presentation, ASHP Midyear Clinical Meeting, Las Vegas. December 2012  

Onysko M. “Evidence-based controversies involving dietary supplements” – Podium presentation, American Pharmacists Association Self-Care Institute, Washington DC, June 2012

Publications (Refereed Journals):

Mlodinow S., Onysko M., Vandiver J., Hunter M., Mahvan T. “Statin therapy – When to worry about adverse effects” Journal of Family Practice 2014;(63)9:497-506.

Reeder CD, Onysko M. “Does weight loss as a result of surgery increase libido in men with low sex drive?” Evidence-Based Practice 2014;17(8)E16.

Winslow B., Onysko M., Thompson K., Caldwell K., Ehlers G., “Common Questions About Clostridium difficile Infection” American Family Physician 2014;89(6):437-442.

Vandiver JW., Faulkner D., Erlandson M., Onysko M. “Is a novel anticoagulant right for your patient?” Journal of Family Practice 2014;63(1):22-8.

Onysko M., Rutten M.(student author), “Are postmenopausal women taking calcium supplementation at an increased risk of myocardial infarction?” Evidence-Based Practice 2013;17(10)11-12.

Leach K., Onysko M. “How common is tachysystole with fetal heart rate abnormalities when inducing labor with misoprostol?” Evidence-Based Practice 2013;16(9)14.

Mah N., Onysko M. “In a patient with hyperlipidemia, what target triglyceride level should be used to eliminate the risk of pancreatitis?” Evidence-Based Practice 2013;16(8)10.

Darrow P., Onysko M., Hunter M. “How long should anticoagulation be continued in a patient with a DVT” Evidence-Based Practice 2013;16(8)8.

Underdahl J., Burch J., Onysko M. “Is there any harm to using diuretics in patients with chronic kidney disease?” Evidence-Based Practice 2013;16(6)12.

Engelhardt M., Burch J., Onysko M. “Can imipramine be used for attention deficit disorder?” Evidence-Based Practice 2012;15(12)17-18.

Salveson L., Onysko M. “How common are allergic reactions to topical antibiotics?” Evidence-Based Practice 2012;15(11)13.

Onysko M., Burch J. “Current standards and future treatments of rheumatoid arthritis” Formulary 2012;47:359-368.

Reece M., Winslow B., Onysko M. “Is massage effective for relieving pain from minor back and neck trauma?” Evidence-Based Practice 2012;15(8)9.

Darnell J, Onysko M., Hunter M. “In patients taking warfarin, what are the risks of adding supplemental fish oil?” Evidence-Based Practice 2012;15(6)11-12.

Bradley A. Hunter M., Onysko M. “What are the benefits of Omega-3s in pregnancy?” Evidence-Based Practice 2012;15(2)10.

Hunter M., Onysko M. “What is the most effective first-line medical treatment of patients with primary Raynaud’s phenomenon?” Evidence-Based Practice 2012;15(1)8-9.

Bradley A., Hunter M., Onysko M. “What are the benefits of Omega-3s in pregnancy?” Evidence-Based Practice 2012;15(2)10.

Winslow B., Onysko M., Stob C., Hazlewood K. “The Treatment of Alzheimer’s Disease” American Family Physician. 2011;83(12):1403-1412.

Maxwell J, Winslow B, Onysko M. “Does the uric acid level provide diagnostic information in patients with hyponatremia who are taking a diuretic?” Evidence-Based Practice 2011;14(7)9.

Lange T, Hunter M, Onysko M, Winslow B. “Denosumab (Prolia®) for osteoporosis” Evidence-Based Practice 2011;14(1)1-2.

Hunter M, Onysko M. “Significance of the source of Omega 3 fatty acids” Evidence-Based Practice 2011;14(1)10-11.

1000 E. University Ave. Laramie, WY 82071
UW Operators (307) 766-1121 | Contact Us | Download Adobe Reader

Twitter Icon Youtube Icon Instagram Icon Facebook Icon

Accreditation | Virtual Tour | Emergency Preparedness | Employment at UW | Gainful Employment | Privacy Policy | Harassment & Discrimination | Accessibility Accessibility information icon